What are the requirements for drawing blood for the anti-tissue transglutaminase (tTG) Immunoglobulin A (IgA) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Requirements for Drawing Blood for Anti-Tissue Transglutaminase (tTG) IgA Test

Blood for anti-tTG IgA testing should be collected via direct venipuncture into a standard plastic tube containing 0.109 M sodium citrate as the anticoagulant, with proper sample handling to avoid hemolysis which can significantly affect results.

Blood Collection Procedure

  • Use a straight needle rather than a butterfly needle for venipuncture to minimize contact activation and hemolysis 1
  • If a butterfly needle must be used, use short connecting tubes to reduce the risk of hemolysis 1
  • Apply tourniquet only long enough to locate the vein (ideally 60 seconds or less) to prevent blood cell activation and hemolysis 1
  • Discard the first tube of blood (or at least the first few milliliters in pediatric patients) 1
  • Draw blood directly into the collection tube rather than using a syringe first to prevent activation of coagulation 1
  • Use plastic collection tubes rather than glass tubes to avoid contact activation 1
  • Ensure proper filling of the tube (neither under nor overfilled) for accurate results 1

Sample Handling and Processing

  • Keep blood samples at room temperature after collection 1
  • Process samples as soon as possible, preferably within 1 hour of collection 1
  • Avoid using pneumatic tube transport systems as they can modify test parameters 1
  • Use hand-carrier transport to deliver samples to the laboratory 1
  • Ensure the patient is on a gluten-containing diet when testing for celiac disease to avoid false negative results 2, 3

Important Considerations

  • Hemolysis can significantly affect anti-tTG IgA test results, even when hemolysis is not visibly apparent 4
  • Hemolysis index (HI) ≥25 can yield inconclusive anti-tTG IgA results as TTG is abundant in erythrocytes and released upon hemolysis 4
  • Document any pre-analytical conditions that may potentially influence test results 1
  • Consider measuring total IgA levels along with anti-tTG IgA to rule out IgA deficiency which could affect interpretation 2, 5

Storage Requirements

  • If testing cannot be performed immediately, freeze plasma samples as soon as possible 1
  • For long-term storage, maintain samples at -80°C where coagulation proteins remain stable for at least 2 years 1
  • When using frozen samples, thaw at 37°C before testing 1
  • Avoid using samples that have been freeze-thawed more than once 1

Common Pitfalls to Avoid

  • Prolonged tourniquet application can lead to blood cell activation and affect test results 1
  • Drawing blood from catheters, especially those containing heparin, can contaminate the sample 1
  • Hemolyzed samples can yield falsely decreased anti-tTG IgA values due to released TTG interfering with antibody binding 4
  • Testing while the patient is on a gluten-free diet can lead to false negative results 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Low Secretory Immunoglobulin A (SIgA) in Stool: Causes and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.